Prophylactic vaccines are potent activators of monocyte-derived dendritic cells and drive effective anti-tumor responses in melanoma patients at the cost of toxicity

Dendritic cell (DC)-based immunotherapy is explored worldwide in cancer patients, predominantly with DC matured with pro-inflammatory cytokines and prostaglandin E(2). We studied the safety and efficacy of vaccination with monocyte-derived DC matured with a cocktail of prophylactic vaccines that con...

Full beskrivning

Sparad:
Bibliografiska uppgifter
I publikationen:Cancer Immunol Immunother
Huvudupphovsmän: Bol, Kalijn F., Aarntzen, Erik H. J. G., Pots, Jeanette M., Olde Nordkamp, Michel A. M., van de Rakt, Mandy W. M. M., Scharenborg, Nicole M., de Boer, Annemiek J., van Oorschot, Tom G. M., Croockewit, Sandra A. J., Blokx, Willeke A. M., Oyen, Wim J. G., Boerman, Otto C., Mus, Roel D. M., van Rossum, Michelle M., van der Graaf, Chantal A. A., Punt, Cornelis J. A., Adema, Gosse J., Figdor, Carl G., de Vries, I. Jolanda M., Schreibelt, Gerty
Materialtyp: Artigo
Språk:Inglês
Publicerad: Springer Berlin Heidelberg 2016
Ämnen:
Original Article
Länkar:https://ncbi.nlm.nih.gov/pmc/articles/PMC4779136/
https://ncbi.nlm.nih.gov/pubmed/26861670
https://ncbi.nlm.nih.govhttp://dx.doi.org/10.1007/s00262-016-1796-7
Taggar: Lägg till en tagg
Inga taggar, Lägg till första taggen!

Liknande verk